icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
24 Jun, 2021 17:25

Hope for IBS sufferers as new study suggests synthetic TARANTULA VENOM could help treat condition

Hope for IBS sufferers as new study suggests synthetic TARANTULA VENOM could help treat condition

A component of tarantula venom has been identified as a promising treatment for irritable bowel syndrome (IBS), a chronic disorder that currently has no cure. The chemical has been successfully tested on mice.

IBS is a common chronic condition that can cause abdominal pain and other unpleasant symptoms. Exactly why and how it develops remains unclear and there is no specific treatment, though dietary changes may help some patients. 

A group of researchers from Australia, the US, and Germany may have discovered a method to significantly improve the quality of life of IBS sufferers by blocking the pain in a targeted way.

The study, as described in the American Chemical Society’s Pharmacology & Translational Science journal, was to test a specific protein that can be found in venom produced by some tarantula species. 

Also on rt.com Antibody drug from GSK-Vir substantially reduces hospitalization & deaths among Covid-19 patients, trial finds

Spiders produce neurotoxins, chemicals that attack the neural system, which means the components of their venom affect nerves in various ways. Nerves are used to signal pain, so spider venom has long been seen as a potential source of novel painkillers.

The particular chemical that was tested by the group, Tsp1a, is derived from a Peruvian tarantula, but the scientists managed to synthesize it in a lab. 

The study on mice found that a single Tsp1a treatment delivered into the creature’s colon significantly reduced the occurrence of a pain reflex, indicating pain relief.

In addition, Tsp1a “appeared highly selective and did not interfere with other body functions, suggesting it could be used safely in humans.”

While the study shows promise as a potential treatment for chronic IBS pain, more thorough studies of its activity in the body and immune system will be critical, the researchers say.

Think your friends would be interested? Share this story!